𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acute leukemia following treatment of polycythemia vera and essential thrombocythemia with uracil mustard

✍ Scribed by Ban T. Toh; Stephanie A. Gregory; Dr. William H. Knospe

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
246 KB
Volume
28
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Genetic lesions associated with blastic
Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia
✍ Gianluca Gaidano; Cristina Pastore; Valeria Santini; Josep Nomdedeu; Barbara Gam πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 1 views

Polycythemia vera (PV) and essential thrombocythemia (ET) are chronic myeloproliferative disorders that may progress to acute leukemia in a subset of patients. This study aimed at investigating the genetic lesions associated with the blastic transformation of PV and ET. A panel of PV and ET cases at

Leukemogenic risk of hydroxyurea therapy
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
✍ Nand, Sucha; Stock, Wendy; Godwin, John; Fisher, Susan Gross πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 417 KB πŸ‘ 1 views

In polycythemia Vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%. This risk has been estimated to be 1-5.9% with hydroxyurea (HU) therapy. When compared with historical controls, the risk with use of HU does not a